Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals

Newsylist Editorial Desk. (2026, October 23, 2026). Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-10-23/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big

@online{newsylist_82072,
  author = {Newsylist Editorial Desk},
  title = {{Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-10-23/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big},
  note = {Tracked across 3 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals](https://www.newsylist.com/trend/2026-10-23/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big)), this event was corroborated across 3 independent sources with a live velocity of 1.